Free shipping on all orders over $ 500

Apomorphine hydrochloride hemihydrate

Cat. No. M55365

All AbMole products are for research use only, cannot be used for human consumption.

Apomorphine hydrochloride hemihydrate Structure
Size Price Availability Quantity
10mg USD 150  USD150 In stock
25mg USD 300  USD300 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Apomorphine hydrochloride hemihydrate is a dopamine D2 agonist.

Chemical Information
Molecular Weight 312.79
Formula C17H17NO2.1/2(H2O).HCl
CAS Number 41372-20-7
Form Solid
Solubility (25°C) Water 15 mg/mL
DMSO 30 mg/mL
Storage 4°C, dry, sealed
Related Dopamine Receptor Products
SV 156

SV 156 is a potent and selective D2 dopamine receptor antagonist, with a Ki of 2.5 nM for hD2. SV 156 has approximately 40-fold binding selectivity for D2 dopamine receptors compared to the D3 receptor subtype.


Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity.


Onzigolide (BIM-23A760), a chimeric dopamine-somatostatin compound, shows potent agonist activity at both DA type 2 (D2R) and SST type 2 (SSTR2) receptors.


CVL-871 is a partial agonist at dopamine D1/5 receptors and may be used in dementia-related studies.

Paliperidone palmitate

Paliperidone palmitate is the ester precursor compound of Paliperidone, a potent dopamine antagonist and 5-HT2A antagonist. Paliperidone is a potent dopamine antagonist and 5-HT2A antagonist.

Abmole Inhibitor Catalog

Keywords: Apomorphine hydrochloride hemihydrate supplier, Dopamine Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.